DM
EWTX icon

Deerfield Management’s Edgewise Therapeutics EWTX Stock Holding History

Deerfield Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-765,694
Closed -$19M – 113
2025
Q4 		$19M Hold
765,694
– – 0.24% 61
2025
Q3 		$12.4M Sell
765,694
-1,301,626
-63% -$18.5M 0.19% 65
2025
Q2 		$27.1M Sell
2,067,320
-11,189
-0.5% -$161K 0.49% 42
2025
Q1 		$45.7M Hold
2,078,509
– – 0.9% 26
2024
Q4 		$55.5M Buy
2,078,509
+297,503
+17% +$9.47M 1.05% 27
2024
Q3 		$47.5M Sell
1,781,006
-1,093,580
-38% -$21.8M 0.71% 31
2024
Q2 		$51.8M Hold
2,874,586
– – 0.86% 29
2024
Q1 		$52.4M Sell
2,874,586
-1,058,551
-27% -$16.8M 0.91% 29
2023
Q4 		$43M Hold
3,933,137
– – 0.79% 33
2023
Q3 		$22.5M Hold
3,933,137
– – 0.5% 41
2023
Q2 		$30.5M Hold
3,933,137
– – 0.65% 36
2023
Q1 		$26.2M Hold
3,933,137
– – 0.58% 45
2022
Q4 		$35.2M Hold
3,933,137
– – 0.73% 41
2022
Q3 		$38.7M Hold
3,933,137
– – 0.77% 44
2022
Q2 		$31.3M Hold
3,933,137
– – 0.65% 48
2022
Q1 		$38.2M Hold
3,933,137
– – 0.85% 37
2021
Q4 		$60.1M Hold
3,933,137
– – 1.26% 25
2021
Q3 		$65.3M Hold
3,933,137
– – 1.27% 22
2021
Q2 		$83.9M Hold
3,933,137
– – 1.49% 13
2021
Q1 		$128M Buy
+3,933,137
New +$128M 2.69% 6

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Deerfield Management's EWTX Position: Q1 2026 in Review

Deerfield Management sold out of Edgewise Therapeutics (EWTX) in Q1 2026, closing a stake of 765,694 shares — an estimated $19M sold.

Deerfield Management first reported a position in EWTX in Q1 2021 and held it in 20 quarters. The position peaked at $128M in Q1 2021. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Deerfield Management reported no remaining Edgewise Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 765,694 Edgewise Therapeutics shares in Q1 2026, an estimated $19M.
  • Deerfield Management first reported a position in Edgewise Therapeutics in Q1 2021 and held it in 20 quarters.
  • Deerfield Management's Edgewise Therapeutics position peaked at $128M in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.